CFR section
21 CFR 56.106(b)(3): Registration
PART 56-INSTITUTIONAL REVIEW BOARDS · Subpart B-Organization and Personnel
Key facts
| Citation | 21 CFR 56.106(b)(3) |
|---|---|
| Section | Registration |
| Part | PART 56-INSTITUTIONAL REVIEW BOARDS |
| Subpart | Subpart B-Organization and Personnel |
| Subchapter | 21 CFR A General |
| Product types cited | General |
| Regulation text (excerpt) | (3) The approximate number of active protocols involving FDA-regulated products reviewed. For purposes of this rule, an “active protocol” is any protocol for which an IRB conducted an initial review or a continuing review at a convened meeting or under an expedited review procedure during the preceding 12 months; and |
At a glance
- 1–9 Inspections citing this section
- 1–9 Warning letters citing this section
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About CFR sections cited by the FDA
Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.